Mavacoxib, CAS 170569-88-7

Product Description: Mavacoxib is a selective, oral long-acting cyclooxygenase-2 (COX-2) inhibitor and a long-acting non-steroidal anti-inflammatory drug (NSAID). Mavacoxib is used to treat pain and inflammation associated with degenerative joint disease in dogs[1].

Applications: Neuroscience-Neuromodulation

Formula: C16H11F4N3O2S

References: [1]Hurst EA, et al. The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels. Vet Comp Oncol. 2019 Jun;17(2):194-207./[2]Cox SR, et al. Population pharmacokinetics of mavacoxib in osteoarthritic dogs. J Vet Pharmacol Ther. 2011 Feb;34(1):1-11.

CAS Number: 170569-88-7

Molecular Weight: 385.34

Compound Purity: 99.04

Research Area: Inflammation/Immunology

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: COX

• SKU: MEXHY-119447-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-119447-10.1
• Package Unit: 10mM/1mL
• Quantity Unit: STK